LaunchPad: Exams/Dispensing Diopsys Intros Latest Electrophysiology Testing Technology By Staff Monday, June 11, 2018 12:11 AM Products: Diopsys Retina Plus and multifocal electroretinography (mfERG) moduleTop Line: Diopsys recently unveiled two new additions to its product portfolio: the Diopsys Retina Plus, the most advanced flicker electroretinography (ERG) system, scalable to create a complete visual electrophysiology suite; and a multifocal electroretinography (mfERG) module for use with Diopsys Nova, Diopsys Argos or the new Retina Plus platforms. These new tools are designed to help eyecare specialists gather objective, quantifiable information about the function of the retina.Close Up: Diopsys Retina Plus is a carry-case sized device that offers clinicians a more convenient way to conduct flicker ERG testing, with the added ability to scale the system to a full visual electrophysiology suite, including multifocal, flash, and pattern ERG, as well as visual evoked potential (VEP). The new device complements existing cart-based (Diopsys Nova) and tabletop (Diopsys Argos) systems in a robust portfolio of testing platforms intended to provide clinics of all sizes access to visual electrophysiology testing.Vital Stats: Diopsys mfERG is a test of localized retinal function, which measures the electrophysiological activity of individual regions within the retina that span the central 42 degrees. The test records responses primarily from bipolar cells combined with contributions from photoreceptor cells. With capability to detect retinal functional losses due to maculopathies, mfERG has several applications in eye care. The American Academy of Ophthalmology (AAO) recommends the use of mfERG for chloroquine (CQ) and hydroxychloroquine (HCQ) retinopathy screening.www.diopsys.com